Clinical Trials Logo

Arthritis clinical trials

View clinical trials related to Arthritis.

Filter by:

NCT ID: NCT00239382 Completed - Clinical trials for Arthritis, Rheumatoid

A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis

Start date: July 1, 2004
Phase: Phase 3
Study type: Interventional

The objective of this trial was to assess the efficacy and safety of 15 mg meloxicam i.m. once daily compared with 15 mg meloxicam tablets once daily p.o. in patients with Rheumatoid arthritis over a time period of 7 days.

NCT ID: NCT00236366 Completed - Osteoarthritis Clinical Trials

A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, Compared With Placebo in Patients With Osteoarthritis

Start date: June 2002
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine if fentanyl, delivered through the skin via an adhesive patch, has a superior pain-relieving effect compared with placebo in patients with osteoarthritis pain that is inadequately controlled by therapeutic treatment with weak opioids, which are often taken in combination with non-opioid analgesics.

NCT ID: NCT00236028 Completed - Clinical trials for Rheumatoid Arthritis

A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of infliximab (Remicade) in patients with early rheumatoid arthritis.

NCT ID: NCT00235885 Completed - Psoriatic Arthritis Clinical Trials

Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)

STEREO
Start date: July 2005
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the safety and clinical efficacy of adalimumab in active psoriatic arthritis (PsA) subjects when adalimumab is added to insufficient standard therapy including patients that have failed other TNF therapies

NCT ID: NCT00235872 Completed - Clinical trials for Rheumatoid Arthritis

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Start date: August 2004
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the long-term safety and tolerability of repeated administration of adalimumab in Japanese subjects with rheumatoid arthritis.

NCT ID: NCT00235859 Completed - Clinical trials for Rheumatoid Arthritis

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

Start date: July 2003
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the safety and efficacy of adalimumab compared to placebo in subjects with rheumatoid arthritis on methotrexate therapy.

NCT ID: NCT00235833 Completed - Clinical trials for Rheumatoid Arthritis

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Start date: June 2003
Phase: Phase 2
Study type: Interventional

The purpose of the study is to assess the long-term safety, tolerability, and efficacy of repeated administration of adalimumab in adult Japanese subjects with rheumatoid arthritis.

NCT ID: NCT00234936 Completed - Clinical trials for Rheumatoid Arthritis

Quality of Life Study With Adalimumab in Rheumatoid Arthritis

Start date: December 2003
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the ability of adalimumab combined with methotrexate to improve the quality of life in patients with active RA.

NCT ID: NCT00234897 Completed - Clinical trials for Rheumatoid Arthritis

Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

HERO
Start date: August 2004
Phase: Phase 4
Study type: Interventional

The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment

NCT ID: NCT00234884 Completed - Clinical trials for Rheumatoid Arthritis

Post-marketing Observational Study in Subjects With Rheumatoid Arthritis

ReAlise
Start date: September 2003
Phase: Phase 4
Study type: Observational

The purpose of this observational study was to observe and assess the long term use, safety, and effectiveness of adalimumab in a normal clinical setting.